220. Rapidly progressive glomerulonephritis Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 4 / Drugs : 9 - (DrugBank : 5) / Drug target genes : 3 - Drug target pathways : 14
Rapidly progressive glomerulonephritis and other diseases between which drug repositioning (DR) might occur (Sakate and Kimura 2021) . Circle size: Number of drugs, Line breadth: Score (Drug repositionability)
| ID | Diseases (Sorted by score) | Score |
|---|---|---|
| 220 | Rapidly progressive glomerulonephritis | - |
| 30 | Distal myopathy | 1.000 |
| 90 | Retinitis pigmentosa | 1.000 |
| 13 | Multiple sclerosis | 1.000 |
| 6 | Parkinson disease | 1.000 |
| 299 | Cystic fibrosis | 1.000 |
| 2 | Amyotrophic lateral sclerosis | 1.000 |
| 62 | Paroxysmal nocturnal hemoglobinuria | 1.000 |
| 63 | Idiopathic thrombocytopenic purpura | 1.000 |
| 75 | Cushing disease | 1.000 |
| 94 | Primary sclerosing cholangitis | 1.000 |
| 39 | Toxic epidermal necrolysis | 1.000 |
| 19 | Lysosomal storage disease | 1.000 |
| 35 | Pemphigus | 1.000 |
| 46 | Malignant rheumatoid arthritis | 1.000 |
| 49 | Systemic lupus erythematosus | 1.000 |
| 51 | Scleroderma | 1.000 |
| 60 | Aplastic anemia | 1.000 |
| 61 | Autoimmune hemolytic anemia | 1.000 |
| 65 | Primary immunodeficiency | 1.000 |
| 66 | IgA nephropathy | 1.000 |
| 84 | Sarcoidosis | 1.000 |
| 85 | Idiopathic interstitial pneumonia | 1.000 |
| 86 | Pulmonary arterial hypertension | 1.000 |
| 96 | Crohn disease | 1.000 |
| 98 | Eosinophilic gastro-intestinal disorder | 1.000 |
| 127 | Frontotemporal lobar degeneration | 1.000 |
| 222 | Primary nephrotic syndrome | 1.000 |
| 283 | Acquired pure red cell aplasia | 1.000 |
| 285 | Fanconi anemia | 1.000 |
| 331 | Idiopathic multicentric castleman disease | 1.000 |
| 53 | Sjogren syndrome | 1.000 |
| 271 | Ankylosing spondylitis | 1.000 |
| 26 | HTLV-1-associated myelopathy | 1.000 |
| 28 | Systemic amyloidosis | 1.000 |
| 162 | Pemphigoid | 1.000 |
| 228 | Bronchiolitis obliterans | 1.000 |
| 113 | Muscular dystrophy | 1.000 |
| 78 | Hypopituitarism | 1.000 |
| 74 | Prolactin secreting pituitary adenoma | 1.000 |
| 79 | Homozygous familial hypercholesterolemia | 1.000 |
| 93 | Primary biliary cholangitis | 1.000 |
| 38 | Stevens-Johnson syndrome | 1.000 |
| 50 | Dermatomyositis | 1.000 |
| 56 | Behcet disease | 1.000 |
| 107 | Juvenile idiopathic arthritis | 1.000 |
| 298 | Hereditary pancreatitis | 1.000 |
| 16 | Crow-Fukase syndrome | 1.000 |
| 97 | Ulcerative colitis | 1.000 |
| 300 | IgG4-related disease | 1.000 |
| 81 | Congenital adrenal hyperplasia | 1.000 |
| 296 | Biliary atresia | 1.000 |
| 164 | Oculocutaneous albinism | 1.000 |
| 40 | Takayasu arteritis | 1.000 |
| 41 | Giant cell arteritis | 1.000 |
| 226 | Interstitial cystitis with Hunners ulcer | 1.000 |
| 269 | Pyogenic arthritis | 1.000 |
| 42 | Polyarteritis nodosa | 1.000 |
| 43 | Microscopic polyangiitis | 1.000 |
| 45 | Eosinophilic granulomatosis with Polyangiitis | 1.000 |
| 95 | Autoimmune hepatitis | 1.000 |
| 284 | Diamond-Blackfan anemia | 1.000 |
| 11 | Myasthenia gravis | 1.000 |
| 44 | Wegener granulomatosis | 1.000 |
| 70 | Spinal stenosis | 1.000 |
| 224 | Purpura nephritis | 1.000 |
| 288 | Autoimmune acquired coagulation factor deficiency | 1.000 |
| 3 | Spinal muscular atrophy | 1.000 |
| 145 | West syndrome | 1.000 |
| 251 | Urea cycle disorder | 1.000 |
| 14 | Chronic inflammatory demyelinating polyneuropathy | 1.000 |
| 18 | Spinocerebellar degeneration | 1.000 |
| 205 | Fragile X syndrome related disease | 1.000 |
| 83 | Addison disease | 1.000 |
| 64 | Thrombotic thrombocytopenic purpura | 1.000 |
| 25 | Progressive multifocal leukoencephalopathy | 1.000 |
| 211 | Hypoplastic left heart syndrome | 1.000 |
| 257 | Hepatic glycogenosis | 1.000 |
| 235 | Hypoparathyroidism | 1.000 |
| 307 | Canavan disease | 1.000 |